HIV Ireland
NewsDesk Weekly
22 January 2016
HIV
HPSC - Weekly HIV & STI Report - Weeks 2, 2016
Latest data from the Health Protection Surveillance Centre show 9 new cases for week 2-2015, bringing the total to 19 HIV new notifications for 2016 to date.
Can we improve acceptance of HIV testing?
Medical Xpress, 19 January 2016
In the first randomized controlled trial to evaluate consent for HIV testing, the results show that opt-out HIV testing can substantially increase the number of patients accepting tests, while opt-in schemes may reduce testing.
See also:
How to Get More People to Take HIV Tests
Pacific Standards, 20 January 2016
I'm an HIV Activist, and I Support the FDA Gay Blood Ban
The Body, 19 January 2016
Activist Matthew Ebert talks about public health, HIV and STIs in the MSM community, prevention, and FDA policies on gay blood ban and celibacy.
Why We Need Law to Relieve Effects of HIV Meds
The Advocate, 18 January 2016
A Massachusetts bill could offer medical insurance relief to people with lipodystrophy, the stigmatizing signature of early HIV medications.
Country's Largest Psychological Organization May Condemn HIV Criminalization
The Advocate, 15 January 2016
The American Psychological Association is reportedly on the verge of releasing a policy statement condemning HIV criminalization.
5 Dating Don'ts for the Newly HIV-Positive
Advocate, 20 January 2016
For the newly diagnosed, there is nothing quite as intimidating as the thought of getting back out into the dating scene. Here are five dating don’ts to follow.
Sexually active U.S. teens, young adults not getting HIV tests
Reuters, 20 January 2016
According to a new report from the CDC, most US high school students and young adults who have sex don’t get HIV tests. On average, just 22 percent of high school students and 33 percent of young adults aged 18 to 24 who report ever having sexual intercourse also report being tested at least once for HIV.
National HIV Prevention: Where's the £1.2m?
NAT, 18 January 2016
NAT comments on the Public Health England’s new £1.2 million tender for a national HIV prevention programme.
Two cases of PrEP failure on solo tenofovir pose significant research questions
Aidsmap, 14 January 2016
A report presented to the 2015 BHIVA conference details two cases where therapeutic levels of solo Tenofovir unequivocally failed to prevent HIV infection in MSM. These cases raise various issues such as the levels of medication required to prevent the infection, the presence of co-infections, and the use of more than one drug for PrEP.
D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease
Aidsmap, 21 January 2016
Long-term therapy with the antiretroviral drug tenofovir increases the risk of end-stage liver disease and liver cancer, according to data from the D:A:D study published in the online edition of AIDS. Five-year cumulative use of the drug increased the relative risk of serious liver disease by 46%.
Number of Russians with HIV Hits 1 Million
The Moscow Times, 20 January 2016
According to the Interfax news agency, the number of HIV-positive patients registered in Russia has reached one million. According to experts' estimates, the number of HIV-positive people in Russia may be closer to 1.5 million, as the entire population has not been examined.
Drugs
West End clinic becomes North America’s second legal supervised injection facility
The Georgia Straight, 15 January 2016
A clinic in Vancouver’s West End is now the second sanctioned supervised-injection facility in North America. Staff at the Dr Peter Centre are now legally permitted to deliver health-care services to heroin addicts that include providing a safe environment for intravenous drug use and supplying users with needles and other equipment used to inject heroin.